Effect of dose constraint on the thyroid gland during locoregional intensity-modulated radiotherapy in breast cancer patients

被引:14
作者
Haciislamoglu, Emel [1 ]
Canyilmaz, Emine [1 ]
Gedik, Sonay [2 ]
Aynaci, Ozlem [2 ]
Serdar, Lasif [2 ]
Yoney, Adnan [1 ]
机构
[1] Karadeniz Tech Univ, Dept Radiat Oncol, Fac Med, Trabzon, Turkey
[2] Kanuni Res & Educ Hosp, Dept Radiat Oncol, Trabzon, Turkey
关键词
breast cancer; dose constraint; supraclavicular radiotherapy; thyroid gland dose; RADIATION-INDUCED HYPOTHYROIDISM; RETROSPECTIVE ANALYSIS; NECK-CANCER; HEAD; RISK; THERAPY; THYROTROPIN; HORMONE; FIELD;
D O I
10.1002/acm2.12668
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The aim of the present study was to compare radiation dose received by thyroid gland using different radiotherapy (RT) techniques with or without thyroid dose constraint (DC) for breast cancer patients. Computerized tomography (CT) image sets for 10 patients with breast cancer were selected. All patients were treated originally with opposite tangential field-in field (FinF) for the chest wall and anteroposterior fields for the ipsilateral supraclavicular field. The thyroid gland was not contoured on the CT images at the time of the original scheduled treatment. Four new treatment plans were created for each patient, including intensity-modulated radiotherapy (IMRT) and helical tomotherapy (HT) plans with thyroid DC exclusion and inclusion (IMRTDC(-), IMRTDC(+), HTDC(-), and HTDC(+), respectively). Thyroid DCs were used to create acceptable dose limits to avoid hypothyroidism as follows: percentage of thyroid volume exceeding 30 Gy less than 50% (V-30 < 50%) and mean dose of thyroid (TDmean) <= 21 Gy. Dose-volume histograms (DVHs) for TDmean and percentages of thyroid volume exceeding 10, 20, 30, 40, and 50 Gy (V-10, V-20, V-30, V-40, and V-50, respectively) were also analyzed. The Dmean of the FinF, IMRTDC(-), HTDC(-), IMRTDC(+) and HTDC(+) plans were 30.56 +/- 5.38 Gy, 25.56 +/- 6.66 Gy, 27.48 +/- 4.16 Gy, 18.57 +/- 2.14 Gy, and 17.34 +/- 2.70 Gy, respectively. Median V30 values were 55%, 33%, 36%, 18%, and 17%, for FinF, IMRTDC(-), HTDC(-), IMRTDC(+), and HTDC(+), respectively. Differences between treatment plans with or without DC with respect to D-mean and V-30 values were statistically significant (P < 0.05). When thyroid DC during breast cancer RT was applied to IMRT and HT, the TDmean and V-30 values significantly decreased. Therefore, recognition of the thyroid as an organ at risk (OAR) and the use of DCs during IMRT and HT planning to minimize radiation dose and thyroid volume exposure are recommended.
引用
收藏
页码:135 / 141
页数:7
相关论文
共 38 条
[1]  
Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0
[2]   V30 as a predictor for radiation-induced hypothyroidism: a dosimetric analysis in patients who received radiotherapy to the neck [J].
Akgun, Zuleyha ;
Atasoy, Beste M. ;
Ozen, Zeynep ;
Yavuz, Dilek ;
Gulluoglu, Bahadir ;
Sengoz, Meric ;
Abacioglu, Ufuk .
RADIATION ONCOLOGY, 2014, 9
[3]   Thyroid disorders in patients treated with radiotherapy for head-and-neck cancer: A retrospective analysis of seventy-three patients [J].
Alterio, Daniela ;
Jereczek-Fossa, Barbara Alicja ;
Franchi, Benedetta ;
D'Onofrio, Alberto ;
Piazzi, Valeria ;
Rondi, Elena ;
Ciocca, Mario ;
Gibelli, Bianca ;
Grosso, Enrica ;
Tradati, Nicoletta ;
Mariani, Luigi ;
Boboc, Genoveva Ionela ;
Orecchia, Roberto .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (01) :144-150
[4]   THYROTROPIN-RELEASING-HORMONE IN HYPOTHALAMUS OF RAT [J].
BASSIRI, RM ;
UTIGER, RD .
ENDOCRINOLOGY, 1974, 94 (01) :188-197
[5]   DECREASED RECEPTOR-BINDING OF BIOLOGICALLY INACTIVE THYROTROPIN IN CENTRAL HYPOTHYROIDISM - EFFECT OF TREATMENT WITH THYROTROPIN-RELEASING-HORMONE [J].
BECKPECCOZ, P ;
AMR, S ;
MENEZESFERREIRA, MM ;
FAGLIA, G ;
WEINTRAUB, BD .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (17) :1085-1090
[6]  
Bonato C, 2008, J PEDIATR ENDOCR MET, V21, P943
[7]   PRIMARY HYPOTHYROIDISM IN BREAST-CANCER PATIENTS WITH IRRADIATED SUPRACLAVICULAR LYMPH-NODES [J].
BRUNING, P ;
BONFRER, J ;
DEJONGBAKKER, M ;
NOOYEN, W ;
BURGERS, M .
BRITISH JOURNAL OF CANCER, 1985, 51 (05) :659-663
[8]   THYROID V30 PREDICTS RADIATION-INDUCED HYPOTHYROIDISM IN PATIENTS TREATED WITH SEQUENTIAL CHEMO-RADIOTHERAPY FOR HODGKIN'S LYMPHOMA [J].
Cella, Laura ;
Conson, Manuel ;
Caterino, Michele ;
De Rosa, Nicola ;
Liuzzi, Raffaele ;
Picardi, Marco ;
Grimaldi, Francesco ;
Solla, Raffaele ;
Farella, Antonio ;
Salvatore, Marco ;
Pacelli, Roberto .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (05) :1802-1808
[9]   Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation [J].
Chow, Lionel M. L. ;
Nathan, Paul C. ;
Hodgson, David C. ;
Jenkin, Derek ;
Weitzman, Sheila ;
Grant, Ronald M. ;
Manson, David ;
Bross, Adee ;
Doyle, John J. ;
Danjoux, Cyril ;
Greenberg, Mark L. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (36) :5735-5741
[10]   HYPOTHYROIDISM AS A CONSEQUENCE OF INTENSITY-MODULATED RADIOTHERAPY WITH CONCURRENT TAXANE-BASED CHEMOTHERAPY FOR LOCALLY ADVANCED HEAD-AND-NECK CANCER [J].
Diaz, Roberto ;
Jaboin, Jerry J. ;
Morales-Paliza, Manuel ;
Koehler, Elizabeth ;
Phillips, John G. ;
Stinson, Scott ;
Gilbert, Jill ;
Chung, Christine H. ;
Murphy, Barbara A. ;
Yarbrough, Wendell G. ;
Murphy, Patrick B. ;
Shyr, Yu ;
Cmelak, Anthony J. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (02) :468-476